Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Lebwohl

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Experimental Dermatology|March 8, 2017
Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatmentEmma Guttman-Yassky, James G Krueger, Mark G Lebwohl
The Medical Clinics of North America|June 1, 2021
Newer Therapies in PsoriasisJustin W Marson, Margaret L Snyder, Mark G Lebwohl
Experimental Dermatology|February 13, 2023
Current management of generalized pustular psoriasisNilesh Kodali, Isabella Blanchard, Sruthi Kunamneni, et al.
Cancer Letters|October 22, 2003
Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cellsFiza Singh, Dayuan Gao, Mark G Lebwohl, et al.
Dermatology and Therapy|March 16, 2026
Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2Jerry Bagel, Ranga Gogineni, Asif Shaikh, et al.
The Journal of Dermatological Treatment|May 30, 2018
Treatment of psoriasis with crisaboroleErica B Lee, Mark G Lebwohl, Jashin J Wu
JAMA|February 22, 2023
Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-ReplyMark G Lebwohl, Adelaide A Hebert, Melinda J Gooderham
JAAD Case Reports|November 1, 2021
Cutaneous reaction reported after third Moderna COVID-19 vaccineSophie H Guénin, Mindy Kresch, Emily Elbogen, et al.
Advances in Therapy|June 18, 2023
Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative ReviewAndrew Blauvelt, Andrea Chiricozzi, Benjamin D Ehst, et al.
Journal of the American Academy of Dermatology|August 2, 2003
Cutaneous ulceration caused by methotrexateDana W Kazlow, David Federgrun, Stephen Kurtin, et al.
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Experimental Dermatology|March 8, 2017
Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatmentEmma Guttman-Yassky, James G Krueger, Mark G Lebwohl
The Medical Clinics of North America|June 1, 2021
Newer Therapies in PsoriasisJustin W Marson, Margaret L Snyder, Mark G Lebwohl
Experimental Dermatology|February 13, 2023
Current management of generalized pustular psoriasisNilesh Kodali, Isabella Blanchard, Sruthi Kunamneni, et al.
Cancer Letters|October 22, 2003
Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cellsFiza Singh, Dayuan Gao, Mark G Lebwohl, et al.
Dermatology and Therapy|March 16, 2026
Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACE 1 and reSURFACE 2Jerry Bagel, Ranga Gogineni, Asif Shaikh, et al.
The Journal of Dermatological Treatment|May 30, 2018
Treatment of psoriasis with crisaboroleErica B Lee, Mark G Lebwohl, Jashin J Wu
JAMA|February 22, 2023
Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-ReplyMark G Lebwohl, Adelaide A Hebert, Melinda J Gooderham
JAAD Case Reports|November 1, 2021
Cutaneous reaction reported after third Moderna COVID-19 vaccineSophie H Guénin, Mindy Kresch, Emily Elbogen, et al.
Advances in Therapy|June 18, 2023
Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative ReviewAndrew Blauvelt, Andrea Chiricozzi, Benjamin D Ehst, et al.
Journal of the American Academy of Dermatology|August 2, 2003
Cutaneous ulceration caused by methotrexateDana W Kazlow, David Federgrun, Stephen Kurtin, et al.
Pageof 21